​PreveCeutical Announces the Appointment of Dr. Harendra Parekh as Chief Research Officer

Spotlight Companies  |

PreveCeutical Medical Inc.(“PMI”)a health and wellness company focused on utilizing nature and science for the benefit of health-conscious consumers, is pleased to announce the appointment of Dr. Harendra (“Harry”) Parekh, Ph.D., BSc., Hons I, as Chief Research Officer (“CRO”) and the entry into a consulting agreement with Dr. Parekh for the same effective May 15, 2017.

Dr. Harry Parekh is based at the University of Queensland’s (UQ) Pharmacy Australia Centre of Excellence (PACE). Dr. Parekh also holds adjunct positions at the National University of Singapore, as well as Manipal University in Manipal, Karnataka, India. Dr. Parekh heads the Drug/Gene Delivery Group at PACE-UQ with his team developing highly innovative and translational medicine delivery systems in conjunction with physicians whose expertise span cancer, obesity and diabetes, macular disease, infectious disease and Traditional Chinese Medicine.

Stephen Van Deventer, PMI’s Chairman and Chief Executive Officer, had this to say on Dr. Parekh’s appointment:

“Dr. Parekh will bring a wealth of experience and expertise to PreveCeutical, positioning us for further growth within our industry. As our Chief Research Officer, we look forward to his guidance on our ongoing and future research and development (R&D) initiatives. We are excited to have him as a part of our team. Welcome aboard.”

Dr. Harry Parekh, of the University of Queensland’s School of Pharmacy, shared Mr. Van Deventer’s sentiments stating:

“PreveCeutical’s R&D focused growth strategy coupled with the passion its management holds for excellence in research were key factors in my decision to join the company as its Chief Research Officer. This is a very exciting opportunity building on my many years of industry-focused research endeavours pursued at and supported by The University of Queensland’s School of Pharmacy. I look forward to working with the experienced PreveCeutical team to further enhance their research initiatives on the world stage.”

About PreveCeutical

For more information about PreveCeutical, please visit http://www.preveceutical.com/, follow us on Twitter: https://twitter.com/preveceuticals, or on Facebook: http://www.facebook.com/Preveceutical

Disclosure: In the interest of full disclosure, we call the reader's attention to the fact that Equities.com, Inc. is compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way be considered as a recommendation to buy, sell or hold these securities. Equities.com is not a registered broker dealer, investment advisor, financial analyst, investment banker or other investment professional. We are a publisher of original and third party news and information. All profiles are based on information that is available to the public. The information contained herein should not be considered to be complete and is not guaranteed by Equities.com to be free from misstatement or errors. The views expressed are our own and not intended to be the basis for any investment decision. Readers are reminded to do their own due diligence when researching any companies mentioned on this website. Always bear in mind that investing in early-stage companies is risky and you are encouraged to only invest an amount that you can afford to lose completely without any change in your lifestyle. Equities has been compensated with cash, common shares and/or warrants for market awareness services provided.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer.

Companies

Symbol Name Price Change % Volume
CAA:CNX PREV:CNX iPath Bloomberg Commodity Index Total Return ETN n/a n/a n/a n/a

Comments

Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     

What Is Petrolithium?

MGX Minerals explains the advantages of petrolithium and how they are helping to solve future problems today.